Toggle light / dark theme

Personalized smart guns, which can be fired only by verified users, may finally become available to U.S. consumers after two decades of questions about reliability and concerns they will usher in a new wave of government regulation.

Four-year-old LodeStar Works on Friday unveiled its 9mm smart handgun for shareholders and investors in Boise, Idaho. And a Kansas company, SmartGunz LLC, says law enforcement agents are beta testing its product, a similar but simpler model.

Both companies hope to have a product commercially available this year.

Kamose, the last king of the Theban Seventeenth Dynasty, refers to Apepi as a “Chieftain of Retjenu” in a stela that implies a Levantine background for this Hyksos king. A ‘normative inversion’ (cite Maimonides, John Spencer, Freud et al) turns the anti-Kemetic Hyksos monotheistic Set of Avaris into the equally sociopathic plague-maker of Exodus and Genesis. Two sides of the same monotheistic coin? Monotheism takes roots from the banning (and/or eradication) of all rival cults.

Egyptian accounts support Manetho and his implication that Moses is King Apophis or final Hyksos king Khamudi, “Josephus associated the Hyksos with the Exodus of the Israelites from Egypt. Many modern scholars believe the Hyksos may have partially inspired the Biblical account.” Geraty, L. T. (2015). “Exodus Dates and Theories”. In Thomas E. Levy; Thomas Schneider; William H.C. Propp (eds.). Israel’s Exodus in Transdisciplina ry Perspective: Text, Archaeology, Culture, and Geoscience. Springer. pp. 55–64. ISBN 978−3−319−04768−3.

“This is a great struggle between the truth and the delusion. This whole material world is in reality a prison for our souls, and its creator who is ignorantly revered as the supreme God by the Jews and Christians (and later also Muslims), is in fact a fallen angel, Ptahil, who listened to the whispering of the King of Darkness.”

Controversial facial recognition company, Clearview AI, which has amassed a database of some 10 billion images by scraping selfies off the Internet so it can sell an identity-matching service to law enforcement, has been hit with another order to delete people’s data.

France’s privacy watchdog said today that Clearview has breached Europe’s General Data Protection Regulation (GDPR).

In an announcement of the breach finding, the CNIL also gives Clearview formal notice to stop its “unlawful processing” and says it must delete user data within two months.

The government wants to have a “search engine for faces,” but the experts are wary.

If you haven’t heard of Clearview AI then you should, as the company’s facial recognition technology has likely already spotted you. Clearview’s software goes through public images from social media to help law enforcement identify wanted individuals by matching their public images with those found in government databases or surveillance footage. Now, the company just got permission to be awarded a U.S. federal patent, according to Politico.

The firm is not without its fair share of controversy. It has long faced opposition from privacy advocates and civil rights groups. The first says it makes use of citizens’ faces without their knowledge or consent. The latter warns of the fact that facial recognition technology is notoriously prone to racially-based errors, misidentifying women and minorities much more frequently than white men and sometimes leading to false arrests.

Clearview AI is about to get formal acknowledgment for its controversial facial recognition technology. Politico reports Clearview has received a US Patent and Trademark Office “notice of allowance” indicating officials will approve a filing for its system, which scans faces across public internet data to find people from government lists and security camera footage. The company just has to pay administrative fees to secure the patent.

In a Politico interview, Clearview founder Hoan Ton-That claimed this was the first facial recognition patent involving “large-scale internet data.” The firm sells its tool to government clients (including law enforcement) hoping to accelerate searches.

As you might imagine, there’s a concern the USPTO is effectively blessing Clearview’s technology and giving the company a chance to grow despite widespread objections to its technology’s very existence. Critics are concerned Clearview is building image databases without targets’ knowledge or permission, and multiple governments (including Australia and the UK) believe the facial recognition violates data laws. The tech could theoretically be used to stifle political dissent or, in private use, to stalk other people. That’s not including worries about possible gender and race biases for facial recognition as a whole.

Citizen journalist now close to death.

Citizen journalist Zhang Zhan is in a Chinese prison for reporting from Wuhan during the height of the city’s coronavirus outbreak in 2020. Her family says she is on hunger strike and could be near death. All calls for her release have gone unheeded.

“Zhang Zhan distributed independent information on what happened in Wuhan,” the managing director of Reporters Without Borders Germany, Christian Mihr, told DW. He asked Germany and the EU to be more outspoken ahead of the 2022 Winter Olympics in Beijing.


For more news go to:
Follow DW on social media:
Für Videos in deutscher Sprache besuchen Sie:

#China #ZhangZhan #Wuhan

Most times when we think of deepfakes, we think of the myriad negative applications. From pornography to blackmail to politics, deepfakes are a product of machine learning. They create a lie that is so realistic that it is hard to believe it is not the real thing. In a society plagued by fake news, deepfakes have the potential to do a substantial amount of harm.

But a recent team of researchers found another use for deepfakes — to deepfake the mind. And using machine learning to simulate artificial neural data in this way may make a world of difference for those with disabilities.

For people with full body paralysis, the body can seemingly become a prison. Communicating and the simplest of tasks may appear to be an insurmountable challenge. But even if the body is frozen, the mind may be very active. Brain-computer interfaces (BCIs) offer a way for these patients to interact with the world.

BCIs do not rely on muscle or eye movements. Instead, the user is trained to manipulate an object using the power of thought alone. BCIs can allow a fully paralyzed person to operate a wheelchair by just thinking, to move a cursor on a computer screen, or even play pinball by moving the paddles with their mind. BCIs can be freeing for people with this type of paralysis. It can also be used to treat depression or to rehabilitate the brain.

Full Story:

This new reality promises robotic dogs to enforce social distancing and publicly owned flying taxis to provide transportation since private vehicles are only available to the rich. The technology is currently being rolled out in other western nations, including Canada.

On a hard disk somewhere in the surveillance archives of Singapore’s Changi prison is a video of Jolovan Wham, naked, alone, performing Hamlet.

The notorious Emotet malware is staging a comeback of sorts nearly 10 months after a coordinated law enforcement operation dismantled its command-and-control infrastructure in late January 2021.

According to a new report from security researcher Luca Ebach, the infamous TrickBot malware is being used as an entry point to distribute what appears to be a new version of Emotet on systems previously infected by the former. The latest variant takes the form of a DLL file, with the first occurrence of the deployment being detected on November 14.

The antibody therapy, REGEN-COV, is currently authorized in the United States to treat people with mild-to-moderate COVID-19 and for prevention of infection in those exposed to infected individuals, and others at high risk of exposure in settings such as nursing homes or prisons. [USN: L4N2P640O]

The extended authorization could help boost sales of Regeneron’s antibody cocktail, in the face of competition from oral COVID-19 pills such as those being developed by Pfizer Inc (PFE.N) and Merck & Co (MRK.N).

Regeneron Pharmaceuticals Inc said on Monday a single dose of its antibody cocktail reduced the risk of contracting COVID-19 by 81.6% in a late-stage trial, in the two to eight months period following the drug’s administration.